Economic Analysis of Orphan Drug Research and Development
10.6039/j.issn.1001-0408.2017.32.03
- VernacularTitle:孤儿药研发的经济学分析
- Author:
Jiangting YU
1
;
Yanhui WANG
;
Dong HUA
Author Information
1. 南京中医药大学卫生经济管理学院
- Keywords:
Orphan drug;
External;
Transaction costs;
Research and development;
Economic analysis
- From:
China Pharmacy
2017;28(32):4474-4478
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the research and development (R&D) of orphan drug in China from the respect of economics,and to provide suggestions for the development and policy formulation of orphan drug in China.METHODS:The theories of external economy and transaction costs were adopted to analyze the reasons about no enthusiasm in orphan drug R&D,and find some appropriate solutions for them.RESULTS:Orphan drug was still lack of identification standard in China.The extemal economy,much of transaction costs in orphan drug and R&D risk aggravated the economic burden on pharmaceutical enterprises,combated R&D and production enthusiasm of pharmaceutical enterprises.CONCLUSIONS:Chinese pharmaceutical enterprises can take part in orphan drug cooperative R&D,and play the advantage of TCM treatment so as to reduce R&D cost.The government should establish and develop orphan drug system,play the role of taxation and health insurance,accelerate approval,give market exclusivity for pharmaceutical enterprises and encourage cooperative R&D.
